共 224 条
[21]
Ma Z(2020)Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: a systematic review and network meta-analysis PLoS Med 20 204-undefined
[22]
Zhang Y(2021)COVID-19-associated acute respiratory distress syndrome versus classical acute respiratory distress syndrome (a narrative review) Iran J Microbiol 14 1538-undefined
[23]
Lin L(2022)The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials Expert Rev Anti Infect Ther 27 19-undefined
[24]
Chen Y(2023)Use of traditional Chinese medicine for the treatment and prevention of COVID-19 and rehabilitation of COVID-19 patients: an evidence mapping study Front Pharmacol 32 S166-undefined
[25]
Xie J(2021)Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study Clin Microbiol Infect 10 18-undefined
[26]
Wu W(2022)Intravenous immunoglobulin (IVIg) therapy in hospitalised adult COVID-19 patients: a systematic review and meta-analysis Rev Med Virol 372 603-undefined
[27]
Li S(2022)Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial Lancet Respir Med 130 38-undefined
[28]
Hu Y(2021)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews BMJ 26 163-undefined
[29]
Hu M(2020)Antiviral agents, glucocorticoids, antibiotics, and intravenous immunoglobulin in 1142 patients with coronavirus disease 2019: a systematic review and meta-analysis Pol Arch Intern Med 223 undefined-undefined
[30]
Chen L(2022)Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort study Crit Care 22 undefined-undefined